⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15482 | 1.00 | — | — | |
| Xenon Xe 127 SCHEMBL29435140 | 1.00 | — | — | |
| SCHEMBL29360521 | 1.00 | — | — | |
| SCHEMBL29449400 | 1.00 | — | — | |
| SCHEMBL1394588 | 1.00 | — | — | |
| Fluoride SCHEMBL81457 | 0.71 | — | — | |
| SCHEMBL1521709 | 0.71 | — | — | |
| SCHEMBL8373754 | 0.71 | — | — | |
| SCHEMBL1643605 | 0.71 | — | — | |
| SCHEMBL1586508 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 155 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4388083-A1 | VASCULARIZED ORGANOIDS | Children's Hospital Medical Center (US) | 2024-06-26 | — | — | EP | disclosed |
| EP-4297849-A1 | INDEPENDENT MODULATION OF STIMULATION THERAPY WAVEFORMS | Medtronic, Inc. (US) | 2024-01-03 | — | — | EP | disclosed |
| EP-4272408-A1 | CLOUD SCALE MULTI-TENANCY FOR RDMA OVER CONVERGED ETHERNET (ROCE) | Oracle International Corporation (US) | 2023-11-08 | — | — | EP | disclosed |
| EP-4252169-A1 | SYSTEMS, METHODS, AND COMPUTER PROGRAM PRODUCTS FOR AUTHENTICATING DEVICES | Visa International Service Association (US) | 2023-10-04 | — | — | EP | disclosed |
| EP-4251272-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF BLEEDING DISORDERS | Band Therapeutics, LLC (US) | 2023-10-04 | — | — | EP | disclosed |
| WO-2023178047-A1 | SOCIAL MEDIA PROFILE IDENTIFICATION CONNECTED TO CRYPTOGRAPHIC TOKEN | Emoji ID, LLC (US) | 2023-09-21 | — | — | WO | disclosed |
| EP-4165290-A1 | EXHAUST TREATMENT SYSTEM FOR DUAL FUEL ENGINES | BASF Corporation (US) | 2023-04-19 | — | — | EP | disclosed |
| WO-2023023180-A1 | VASCULARIZED ORGANOIDS | CHILDREN’S HOSPITAL MEDICAL CENTER (US) | 2023-02-23 | — | — | WO | disclosed |
| WO-2023023584-A2 | METHODS FOR DETECTING RNA BINDING PROTEIN COMPLEXES | ECLIPSE BIOINNOVATIONS, INC. (US) | 2023-02-23 | — | — | WO | disclosed |
| WO-2022185311-A1 | SYSTEMS AND METHODS FOR MONITORING FLUID OF A FLUID FACILITY HAVING AN INSPECTION SUBSYSTEM FOR INSPECTION OF LIGHT SOURCES USED IN THE MONITORING SYSTEM | MAYTRONICS LTD. (IL) | 2022-09-09 | — | — | WO | disclosed |
| WO-2008067539-A1 | OLEFIN BLOCK COMPOSITIONS FOR HEAVY WEIGHT STRETCH FABRICS | DOW GLOBAL TECHNOLOGIES INC. (US) | 2008-06-05 | — | — | WO | disclosed |
| WO-2008021274-A2 | SURGICAL CUTTER WITH EXCHANGEABLE CUTTER BLADES | TRANS1 INC. (US) | 2008-02-21 | — | — | WO | disclosed |
| WO-2008019616-A1 | ELECTRICAL THIN FILM MEMORY | HONG KONG APPLIED SCIENCE AND TECHNOLOGY RESEARCH INSTITUTE CO., LTD (CN) | 2008-02-21 | — | — | WO | disclosed |
| WO-2007139920-A2 | IMPROVEMENTS IN METHODS AND DEVICES TO CURB APPETITE AND/OR REDUCE FOOD INTAKE | ENDOSPHERE, INC. (US) | 2007-12-06 | — | — | WO | disclosed |
| WO-2007108973-A2 | COVERED POOL | HIDDEN WATER POOLS, INC. (US) | 2007-09-27 | — | — | WO | disclosed |
| WO-2007103342-A2 | ELECTRO-OPTICAL ELEMENT INCLUDING IMI COATINGS | GENTEX CORPORATION (US) | 2007-09-13 | — | — | WO | disclosed |
| WO-2007095122-A2 | SYSTEM, METHOD AND APPARATUS FOR ENHANCED SWEAT CONTROL AND THE LIKE | TAPPER ROBERT (US) | 2007-08-23 | — | — | WO | disclosed |
| WO-2007084997-A2 | FLAT TUBE, FLAT TUBE HEAT EXCHANGER, AND METHOD OF MANUFACTURING SAME | MODINE MANUFACTURING COMPANY (US) | 2007-07-26 | — | — | WO | disclosed |
| WO-2007079130-A2 | COMPOSITIONS CONTAINING, METHODS INVOLVING, AND USES OF NON-NATURAL AMINO ACIDS AND POLYPEPTIDES | AMBRX, INC. (US) | 2007-07-12 | — | — | WO | disclosed |
| WO-2007075326-A2 | METHODS OF USING CD40 BINDING AGENTS | SEATTLE GENETICS, INC. (US) | 2007-07-05 | — | — | WO | disclosed |